These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32591907)

  • 1. Antiresorptive agents-related osteonecrosis of the jaw (ARONJ) in rheumatoid arthritis.
    Fujieda Y; Atsumi T
    J Bone Miner Metab; 2020 Sep; 38(5):739-741. PubMed ID: 32591907
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease.
    Fujieda Y; Doi M; Asaka T; Ota M; Hisada R; Ohnishi N; Kono M; Kameda H; Nakazawa D; Kato M; Amengual O; Takahata M; Yasuda S; Kitagawa Y; Atsumi T
    J Bone Miner Metab; 2020 Jul; 38(4):581-588. PubMed ID: 32076874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of antiresorptive agent-related osteonecrosis of the jaw in patients with rheumatoid arthritis.
    Watanabe R
    J Bone Miner Metab; 2020 Sep; 38(5):737-738. PubMed ID: 32274571
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
    Shibahara T
    Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) in urological malignancies: a multi-center retrospective study.
    Sakai Y; Shindo T; Sato S; Takahashi A; Kunishima Y; Kato R; Itoh N; Okada M; Tachiki H; Taguchi K; Takayanagi A; Hotta H; Horita H; Matsukawa M; Matsuki M; Nishiyama K; Miyazaki A; Hashimoto K; Tanaka T; Masumori N
    J Bone Miner Metab; 2021 Jul; 39(4):661-667. PubMed ID: 33704573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships of opacification in the nasal sinuses, rhinosinusitis, and antiresorptive agent-related osteonecrosis of the jaw.
    Matsumoto Y; Yokoi H; Ikeda T; Kawada M; Saito K
    Auris Nasus Larynx; 2020 Dec; 47(6):996-1002. PubMed ID: 32591168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk?
    Sidhu HK
    Dent Update; 2015 Jun; 42(5):436-8, 440. PubMed ID: 26964445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiresorptive drug-related osteonecrosis of the jaw.
    Uyanne J; Calhoun CC; Le AD
    Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of a xenogeneic collagen matrix on extraction sockets: a new approach in ARONJ prevention (in german)].
    Kuster I; Valdec S; Rücker M; Bichsel D
    Swiss Dent J; 2020 Feb; 130(2):139-145. PubMed ID: 32031353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous Mandibular Nerve Block for Intractable Mandibular Pain Due to Antiresorptive Agent-Related Osteonecrosis of the Jaw: A Case Report.
    Fujimoto D; Obata N; Motoyama Y; Sato H; Takao Y; Mizobuchi S
    Kobe J Med Sci; 2020 Nov; 66(3):E90-E93. PubMed ID: 33431781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis.
    Voss PJ; Steybe D; Poxleitner P; Schmelzeisen R; Munzenmayer C; Fuellgraf H; Stricker A; Semper-Hogg W
    Odontology; 2018 Oct; 106(4):469-480. PubMed ID: 29713913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Incidence of Antiresorptive Agent-Related Osteonecrosis of the Jaw in Urologic Cancers].
    Kawanishi H; Yokozeki H; Hoshiyama A; Watanabe H; Funahashi Y; Fujiwara M; Takashima Y; Shintani M; Yui S; Okumura K
    Hinyokika Kiyo; 2022 Jan; 68(1):1-6. PubMed ID: 35114759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiresorptive agent-related osteonecrosis of the jaw in prostate cancer patients with bone metastasis treated with bone-modifying agents.
    Nakai Y; Kanaki T; Yamamoto A; Tanaka R; Yamamoto Y; Nagahara A; Nakayama M; Kakimoto KI; Ishibashi M; Nishimura K
    J Bone Miner Metab; 2021 Mar; 39(2):295-301. PubMed ID: 32886176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Periodontal Space Widening in Patients with Antiresorptive Drug-related Osteonecrosis of the Jaws (ARONJ) on Panoramic Radiographs.
    Assaf AT; Amberg V; Smeets R; Wikner J; Hanken H; Semmusch J; Ewald F; Rashad A; Friedrich RE
    Anticancer Res; 2018 Sep; 38(9):5305-5314. PubMed ID: 30194182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update MRONJ and perspectives of its treatment.
    Voss PJ; Poxleitner P; Schmelzeisen R; Stricker A; Semper-Hogg W
    J Stomatol Oral Maxillofac Surg; 2017 Sep; 118(4):232-235. PubMed ID: 28697987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current situation and future issues of antiresorptive agent-related osteonecrosis of the jaw].
    Takaoka K; Kishimoto H
    Nihon Yakurigaku Zasshi; 2019; 153(1):22-27. PubMed ID: 30643088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate-associated osteonecrosis of jaw reoccurrence after methotrexate therapy: a case report.
    Alsalleeh F; Keippel J; Adams L; Bavitz B
    J Endod; 2014 Sep; 40(9):1505-7. PubMed ID: 25146044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
    Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging therapies with potential risks of medicine-related osteonecrosis of the jaw: a review of the literature.
    Kanwar N; Bakr MM; Meer M; Siddiqi A
    Br Dent J; 2020 Jun; 228(11):886-892. PubMed ID: 32541753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.